As trade tensions between India and the US escalate with President Trump’s latest tariff announcement, longstanding concerns ...

More than three dozen tech startups with a combined valuation of $100 billion are set to go public by 2027 in what would mark ...

Mumbai: Global brokerage firm Citi said on Tuesday there is a low likelihood of the US imposing tariffs on Indian ...

India's pharmaceutical industry is urging its government to negotiate with Washington from a “position of power” on tariffs ...

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan ...

India has emerged as a growing player in the illicit fentanyl trade, a new US intelligence report says, a designation likely ...

Are pharmaceutical companies earning too much? Deciding whether pharmaceutical companies earn too much money is complicated. In this issue of JAMA, 2 reports take different approaches to the question.

As per a secondary market research analysis by Bain & Company in 2025, India's pharmaceutical exports ranked 11th globally in value terms in 2023, accounting for 3% of total pharmaceutical exports.

The Indian pharmaceutical exports ranked 11th globally in value terms in the year 2023 and accounted for 3% of the total pharmaceutical exports, said Bain and Company in a research report.